Grade My Investments
HomeFree Stock Grades › SVRA

Savara Inc. (SVRA) Stock Grade

SVRA · Healthcare

B
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$1.3B
P/E Ratio
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
Dividend Yield
None

About Savara Inc.'s fundamentals

Savara Inc. is a biotechnology company with a market capitalization of $1.3 billion that reported zero year-over-year revenue growth and a net loss in its latest annual statement, resulting in a net margin of 0.0%. The company does not pay a dividend. Traditional valuation metrics like P/E ratio and return on equity are not applicable given the company's current unprofitability.

Track SVRA free — no credit card required. Live grade + monthly AI report →